Delatestryl and Decreased activity - a phase IV clinical study of FDA data
Summary:
No or too few reports are found.
The phase IV clinical study is created by eHealthMe based on reports from the FDA, and is updated regularly.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 700+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
No or too few reports are found.
What is Delatestryl?
Delatestryl has active ingredients of testosterone enanthate. Currently, eHealthMe is studying from 1,265 Delatestryl users.
What is Decreased Activity?
Decreased activity is found to be associated with 2,308 drugs and 1,239 conditions by eHealthMe. Currently, we are studying 14,421 people who have Decreased activity.
Do you take Delatestryl and have Decreased activity?
Check whether Decreased activity is associated with a drug or a conditionHow to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Related studies
Delatestryl side effects by duration, gender and age:
- Delatestryl side effects (1,265 reports)
Decreased activity treatments and more:
- Decreased activity (14,421 reports)
All the drugs that are associated with Decreased activity:
All the conditions that are associated with Decreased activity:
How the study uses the data?
The study uses data from the FDA. It is based on testosterone enanthate (the active ingredients of Delatestryl) and Delatestryl (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 700+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Depakote and Atonic Seizures - 2 minutes ago
- Psyllium and Breathing Difficulty - 2 minutes ago
- Zylet and Lovenox drug interaction - 2 minutes ago
- Nexium and Blood Creatine Phosphokinase Increased - 3 minutes ago
- Morphine and Relafen drug interaction - 3 minutes ago
- Theophyl and Renal Tubular Necrosis - 3 minutes ago
- Nasacort and Skin Abscess - 3 minutes ago
- Prezista and Mitochondrial Toxicity - 3 minutes ago
- Zide and Heart Rate Increased - 3 minutes ago
- Temazepam and Tendonitis - 4 minutes ago